Luís Meza
University of Iowa(US)Yale University(US)City of Hope(US)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, CAR-T cell therapy research, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer(2002)516 cited
- → Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial(2022)440 cited
- → Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer(2002)291 cited
- → Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23(1996)256 cited
- → A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees(1996)170 cited
- → CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma(2024)127 cited